The discussions demonstrate a shared concern for inequities in clinical trial participation, with phrases like 'important work' and mentions of addressing 'multilevel barriers' indicating a recognition of the study’s relevance. While there is acknowledgment of the study's significance, the tone remains moderate and focused on the broader importance rather than detailed critique or action plans.
AgreementModerate agreement
Most discussions acknowledge the importance of addressing barriers to clinical trial participation based on the shared recognition of inequality issues.
InterestModerate interest
Participants show moderate interest by emphasizing the significance of the study and its interventions, though they do not delve deeply into technical details.
EngagementModerate engagement
Comments reflect some level of engagement, as they mention the need for communication tools and overall importance, but lack extensive analysis or critique.
ImpactModerate impact
The discussions suggest that the study and its findings could influence awareness and future efforts to improve trial participation across different communities.
Abstract in brief
The PACCT study explored the barriers to clinical trial participation among Black and White men with prostate cancer, focusing on systemic and interpersonal issues.
Only a small portion (44 out of 221) of participating patients were potentially eligible for a trial, with higher income being linked to greater eligibility.
The intervention, which included a Question Prompt List to improve communication, increased trial invitations and active participation, especially among Black patients, indicating that communication strategies can help address barriers to trial enrollment.
Cancer clinical trial participation is low and inequitable. @susaneggly, @RCGD_ISR's Louis Penner et al address multilevel barriers to clinical trial participation among Black and White men with prostate cancer with the PACCT study
Dec 26, 2022 · 2 likes · 1 share · 1,152 followersView post →
SE
Susan Eggly ☮️
@susaneggly · X
I don't like Twitter and am looking for a better platform, but in this meantime, I want to get this important work out. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study https://t.co/XlTVHI1uzO
The PACCT study examined systemic and interpersonal barriers to clinical trial participation among Black and White men with prostate cancer. Improved communication strategies, like Question Prompt Lists, increased trial…
Cancer clinical trial participation is low and inequitable. @susaneggly, @RCGD_ISR's Louis Penner et al address multilevel barriers to clinical trial participation among Black and White men with prostate cancer with the PACCT study
Dec 26, 2022 · 2 likes · 1 share · 1,152 followersView post →
SE
Susan Eggly ☮️
@susaneggly · X
I don't like Twitter and am looking for a better platform, but in this meantime, I want to get this important work out. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study https://t.co/XlTVHI1uzO
Kovilakam Et Al-2016-Journal of Geophysical Research ...
News
figured with a prescribed preindustrial control simulation climatology of sea ice and thus is noninteractive. CAM4 ... 5380–5552, doi:10.1002/jgrd.50171. The model ...
Soleymanjahi Et Al 2024 Artificial Intelligence Assisted Colonoscopy ...
News
1490 of 5552. ADR was rated very low given serious ROB, serious [26.8 ... and considerably outperforms the standard DerSimonian-Laird doi:10.1002/cam4.4261
Influence of The Tumor Microenvironment On NK Cell Function in ...
News
doi: 10.1002/eji.201444643 of natural killer cytotoxicity in patients with ... (2018) 24:5552–61. Kuchroo VK, et al. Reversal of NK-cell exhaustion in ...
RD
SE
BL